Table 5 Influencing fators for therapeutic efficacy of DMD patients
Univariate Cox regression | Multivariate Cox regression | |||||
|---|---|---|---|---|---|---|
HR | 95%CI | P | HR | 95%CI | P | |
Age atadmission | 0.851 | 0.771–0.939 | 0.001 | 0.929 | 0.869–0.993 | 0.031 |
Treatment modality | 3.362 | 1.222–5.607 | 0.000 | 4.174 | 2.401–7.495 | 0.003 |
Vignos scale score at admission | 0.637 | 0.454–0.863 | 0.002 | 0.484 | 0.267–0.880 | 0.017 |
Lymphocyte count at admission | 1.056 | 1.003–1.111 | 0.037 | 1.232 | 0.949–1.613 | 0.117 |
Granulocyte count at admission | 0.785 | 0.457–0.954 | 0.048 | 0.604 | 0.278–1.295 | 0.174 |
Granulocyte count at follow-up | 0.481 | 0.254–0.912 | 0.025 | 0.611 | 0.285–1.439 | 0.198 |
Albumin at admission | 1.131 | 1.060–1.206 | 0.002 | 1.250 | 0.941–1.643 | 0.109 |
Eosinophil count at follow-up | 1.895 | 1.313–2.733 | 0.001 | 2.218 | 1.154–3.924 | 0.016 |
Eosinophil count at admission | 1.281 | 0.743–1.572 | 0.684 | 1.147 | 0.904–1.463 | 0.164 |